Board of Directors and Executive Officers
As of December 01, 2025
| Chairman | Asuka Miyabashira (President, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited) |
|---|---|
| Vice Chairman | Osamu Okuda（President and CEO, Chugai Pharmaceutical Co.)
Kenji Yasukawa（Chairman, Astellas Pharma Inc.) Keisuke Naito (Representative Executive Officer and Senior Managing COO, Eisai Co.) Isao Teshirogi (Chairman, President & CEO, Shionogi & Co., Ltd.) Toru Kimura (President, Sumitomo Pharma Co., Ltd.) Jun Manabe (Chairman, Daiichi Sankyo Company, Limited) |
| Executive Board Members | Takashi Horii (President, AstraZeneca K.K.)
Hiromitsu Shirasawa (Chairman, General Manager, Global Research & Development Division, MSD Corporation) Yoshiro Matsuo (Vice President, Otsuka Pharmaceutical Co., Ltd.) Yasuo Takehana (President, Kissei Pharmaceutical Co., Ltd.) Masashi Miyamoto (Chairman and CEO, Kyowa Kirin Company, Limited) Paul Lirette (President, GlaxoSmithKline K.K.) Takahiko Iwaya (President, Sanofi K.K.) Akihisa Harada (Representative Director, CEO, Tanabe Pharma K.K.) Hiroaki Igarashi (President, Pfizer Japan Inc.) |
| Board of Directors | Yoshikazu Aoki (President, Asahi Kasei Pharma Corporation)
Hiroyuki Horiuchi (President, Kaken Pharmaceutical Co., Ltd.) Yutaka Ogiwara (President and CEO, Kyorin Pharmaceutical Co., Ltd.) Yoshihiro Miwa (Chairman and President, Kowa Company, Limited) Takeshi Ito (President and CEO, Santen Pharmaceutical Co.) Shigeru Uehara (President, Taisho Pharmaceutical Co., Ltd.) Masayuki Kobayashi (President, Taiho Pharmaceutical Co., Ltd.) Masaki Taneda (President, Teijin Pharma Limited) Shinmasa Kondo (President, Torii Pharmaceutical Co., Ltd.) Simone Thomsen (President, Eli Lilly Japan K.K.) Toru Nakai (President, Nippon Shinyaku Co., Ltd.) Masataka Ogimura (President, Pharmaceutical Business Unit, Nippon Boehringer Ingelheim K.K.) John Paul Precino (President, Novartis Pharma K.K.) Ashraf Al-Ouf (President, Bayer Yakuhin K.K.) Kazuei Nakatomi (President, Hisamitsu Pharmaceutical Co., Ltd.) Hidehito Katsuma (President, Bristol-Myers Squibb K.K.) Daikichiro Kobayashi (Chairman, Meiji Seika Pharma Co., Ltd.) Naoyuki Mochida (President, Mochida Pharmaceutical Co., Ltd.) Chris Rieger (President, Janssen Pharma K.K.) |
| Auditor | Sodai Yamaguchi (President, Asuka Pharmaceutical Co., Ltd.)
Mitsuhiro Ibe (President and COO, Zeria Pharmaceutical Industries, Ltd.) |
| Chairman of the Board of Directors | Kenshi Kinoshita |
| Executive Director | Yasunori Yoshida |
| Managing Director | Shoko Nakagawa
Yoshiyuki Ishida |